Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Tsukamurella paurometabola peritonitis in a patient on automated peritoneal dial...
Información de la revista
Vol. 39. Núm. 8.
Páginas 422 (Octubre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 39. Núm. 8.
Páginas 422 (Octubre 2021)
Scientific letter
Acceso a texto completo
Tsukamurella paurometabola peritonitis in a patient on automated peritoneal dialysis
Peritonitis por Tsukamurella paurometabola en un paciente en diálisis peritoneal automatizada
Visitas
1425
Rashad Ismayilova,
Autor para correspondencia
ismayilov_r@hotmail.com

Corresponding author.
, Zeynep Cansu Duranb, Gulsen Hazirolanc, Ahmet Çagkan Inkayab
a Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey
b Hacettepe University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey
c Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Dear Editor,

Tsukamurella spp. are gram-positive, mandatory aerobic, saprophyte bacteria found in water, soil, sludge, and it rarely causes infection in humans. Although the risk factors and the route of transmission are not certain, different clinical manifestations such as ocular and cutaneous infections, meningitis, tenosynovitis, prosthetic joint infections, respiratory tract infections, catheter-related bloodstream infections, and peritonitis are reported in the literature.1

We present the case of a 67-year-old male patient with type 2 diabetes mellitus and chronic kidney disease admitted with complaints of abdominal pain and vomiting. The patient was on automated peritoneal dialysis for 8 years. There was not any redness, discharge, and tenderness around the peritoneal catheter insertion site. Laboratory investigation revealed white blood cell count of (WBC) 9.7×103/μL (4.3–10.3×103/μL), neutrophil count 8.53×103/μL (2.1–6.1×103/μL), erythrocyte sedimentation rate (ESR) 20mm/h, C-reactive protein (CRP) 1.21mg/dL (0–0.8mg/dL), and procalcitonin 0.20ng/mL (0–0.1ng/mL). Abdominal computed tomography revealed diffuse contrast enhancement compatible with peritonitis. Thereafter, intravenous ampicillin/sulbactam (SAM), 1000/500mgBID was commenced empirically. Peritoneal fluid cell count was 4400/mm3 with 87.1% of neutrophils. The peripheral blood cultures signaled growth in aerobic bottles of the Bactec FX system (BD, USA) after 34h of incubation. Gram staining from blood culture tubes showed straight, non-branching, Gram-positive rods. The specimens from the bottles were plated onto 5% sheep blood/eosin methylene blue agar (BD) and chocolate agar. On the other hand, peritoneal fluid culture taken from the peritoneal catheter was performed by inoculating sample into 5% sheep blood/eosin methylene blue agar (BD), chocolate agar, and fluid thioglycolate medium. The mediums were incubated at 35°C in 5% CO2. After 24h, white, rough, dry, and non-hemolytic colonies were observed. Gram staining from peritoneal fluid culture showed non-branching, Gram-positive rods, too. The colonies were found to be catalase positive and oxidase negative. Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) system (Bruker, Germany) was used for identification (MBT 7854 MSP Library). The peritoneal fluid isolate identified as Tsukamurella paurometabola with a Bruker score of 2.1 by Bruker Biotyper indicated confident species level identification. The blood culture isolates identified as Tsukamurella spp. with a Bruker score of 1.9 by Bruker Biotyper indicated confident genus level identification. Gentamicin 0.6mg/kg intravenously was added on treatment day 3. Peritoneal fluid pleocytosis decreased to 100/mm3 (22% neutrophil) on treatment day 6. Follow-up peritoneal fluid and blood cultures remained sterile. Gentamicin was discontinued on day 21. As patients’ complaints did not improve, peritoneal dialysis catheter was removed surgically and the patient was put-on routine hemodialysis program on day 35. Peritoneal biopsy sample collected during catheter removal showed fibrotic changes and no sign of any other infection. Intravenous SAM switched to oral amoxicillin/clavulanate on the 37th day of treatment and continued for an additional 14 days. Complaints of patients improved totally after catheter removal.

Tsukamurella spp. have many common features with Rhodococcus, Corynebacterium, Nocardia, and Mycobacterium, which may lead to misidentification. In addition to this, the differentiation of Tsukamurella bacteria at the species level is quite complicated and difficult by conventional methods. At present, the identification of bacteria up to the genus level can be accomplished with 16S rRNA sequencing, but PCR sequencing is still expensive and time-consuming. In contrast, MALDI-TOF MS is a rapid and cost-effective method. This method allows adding MSPs of bacterial species not included in the database to improve its performance. In a study using an expanded database, 98.3% of Tsukamurella isolates were correctly identified at the species level with a score of ≥2.0.2 Currently, the genus is composed of 17 validly identified species.3 MALDI-TOF MS can be used for routine species identification of Tsukamurella in clinical microbiology laboratories after optimization of the database by adding reference MSPs of all known Tsukamurella species.

Tsukamurella spp. are opportunistic pathogens and often cause catheter-induced infections. Previously, cases of peritonitis have been reported in patients receiving continuous ambulatory peritoneal dialysis.4,5 However, there is insufficient information about the clinical course and treatment duration. To our knowledge, the case we presented is the first case of Tsukamurella peritonitis that received automated peritoneal dialysis.

Consequently, Tsukamurella species are very rare in humans, as well as the presence of catheters and poor hygiene may pose a risk.

Funding

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Conflict of interest

None.

References
[1]
S. Safaei, M. Fatahi-Bafghi, O. Pouresmaeil.
Role of Tsukamurella species in human infections: first literature review.
New Microbes New Infect, 22 (2018), pp. 6-12
[2]
J.L.L. Teng, Y. Tang, S.S.Y. Wong, J.Y.H. Fong, Z. Zhao, C.P. Wong, et al.
MALDI-TOF MS for identification of Tsukamurella species: Tsukamurella tyrosinosolvens as the predominant species associated with ocular infections article.
Emerg Microbes Infect, 7 (2018),
[3]
A.C. Parte, J. Sardà Carbasse, J.P. Meier-Kolthoff, L.C. Reimer, M. Göker.
List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ.
Int J Syst Evol Microbiol, (2020), pp. 0-5
[4]
A.J. Shaer, C.A. Gadegbeku.
Tsukamurella peritonitis associated with continuous ambulatory peritoneal dialysis.
Clin Nephrol, (2001),
[5]
J.-C. Park, J.-S. Hong, J.-G. Seo, W.-K. Chung, Y.-H. Seo, H.-H. Lee.
A case of Tsukamurella tyrosinosolvens peritonitis associated with continuous ambulatory peritoneal dialysis.
Korean J Med, 76 (2009), pp. 225-228
Copyright © 2020. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos